Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aquarius intron-binding spliceosomal factor (AQR) is a highly conserved RNA helicase essential for RNA processing and genome integrity. It is involved in pre-mRNA splicing as part of the U2-type spliceosome, providing ATP-dependent helicase activity to facilitate proper RNA maturation. It also serves roles in DNA repair by processing R-loops, affecting homologous recombination and the expression of key DNA repair factors such as CtIP. Aquarius interacts directly with small RNA silencing complexes, thereby contributing to co-transcriptional gene silencing of transposable elements. Dysregulation of AQR can lead to genome instability and is implicated in diseases including cancer and diabetes[1][2][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aquarius intron-binding spliceosomal factor (AQR).